Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (PLAD) of tumor necrosis factor receptors

Details for Australian Patent Application No. 2006261824 (hide)

Owner The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health

Inventors Chan, Francis Ka-Ming; Deng, Guo-Min; Zheng, Lixen; Lenardo, Michael

Agent Griffith Hack

Pub. Number AU-A-2006261824

PCT Pub. Number WO2007/002633

Priority 60/694,015 24.06.05 US; 60/717,589 16.09.05 US

Filing date 26 June 2006

Wipo publication date 4 January 2007

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/002633 Priority application(s): WO2007/002633

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261828-N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions

2006261816-Compositions containing fluorine substituted olefins